Nikang Therapeutics IPO

www.nikangtx.com

NiKang Therapeutics is a biotech company focused on discovering and developing innovative small molecules oncology medicines to help patients with unmet medical needs. The company's strategy enables discovery and advancement of proprietary drug candidates with the most desirable pharmacological features into clinical studies.

Founded2017
Total Funding to Date$260.25MM
Register for Details

For more details on financing and valuation for Nikang Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Nikang Therapeutics Ticker Symbol

Nikang Therapeutics does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Nikang Therapeutics Stock Price

The stock price for Nikang Therapeutics will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Nikang Therapeutics Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
5/26/2021 Series C $475.12MM $XXX.XX $XXX.XX
9/14/2020 Series B1 and B2 $112.62MM $XXX.XX $XXX.XX
7/28/2017 Series A $15.38MM $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Other companies like Nikang Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$317.32MM
Sector
 
 
Sector
Last Round Est. Valuation
$1.59B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$334.19MM